Lumicera Health Services is proud to announce that Eric Huckins has been promoted to Chief Growth Officer, a role in which he will guide the next stage of Lumicera’s expansion, partnerships and specialty pharmacy innovation.
Lumicera Earns URAC Rare Disease Pharmacy Center of Excellence Certification, Reinforcing Commitment to Specialized Patient Care.
Lumicera announces the promotion of Ben Heiser, PharmD, to Senior Vice President and Chief Executive Officer (CEO) during a period of historic growth!
Eric Huckins, our Vice President of Business Development, sat down with the Becker’s Healthcare Podcast Network during their CPO Summit to share his insights on specialty pharmacy for health systems.
At Lumicera, clinical excellence isn’t just a goal, it’s the heart of everything we do. Our dedicated pharmacy team goes above and beyond to provide personalized, patient-focused care each and every day!
This report analyzed the patient acceptance rate and reported outcomes when a pharmacist provided interventions for patients on oral targeted breast cancer therapies in a mail order integrated health system specialty pharmacy.
Lumicera Health Services announced today it will be participating in LEO Pharma’s Limited Distribution Network to dispense Anzupgo® (delgocitinib) Cream, the first and only FDA-approved treatment for moderate-to-severe Chronic Hand Eczema (CHE) in adults.
This report explores the background of 340B covered entities, how they operate and the ways Lumicera’s clinical liaison team optimizes these programs for cost savings.
Lumicera and HealthBeacon are thrilled to announce a new strategic collaboration. This partnership brings together Lumicera’s expertise in specialty pharmacy services and HealthBeacon’s leadership in digital health to improve outcomes for patients on injectable therapies, one dose at a time.
Eric Huckins discusses enhancing specialty pharmacy programs in health systems by addressing challenges like 340B, payer access, and accreditation. He emphasizes the importance of strategic partnerships, biosimilars, and technology in improving patient care and fostering growth.
